CHAPEL HILL, N.C., May 12, 2017 /PRNewswire/ -- Disease state awareness campaigns are one of the few ways to inform patientsand physicians before a product is approved. In essence, they set the table for future marketing efforts at product launch and post-launch.
Disease awareness campaigns have long been used by the pharmaceutical industry to disseminate unbranded
To help pharma leaders better understand how to effectively utilize disease awareness programs to support pipeline portfolio products, Best Practices, LLC has published a new research study that delivers reliable industry metrics on current disease state awareness program structure, spend, and activities.
"Disease Awareness Program Excellence: Structure, Activities & Resources Needed for Effective Pipeline Support" identifies what disease awareness activities and investment levels are most effective for supporting pipeline products during both development and post-marketing periods.
The study provides current insights on questions such as:
Pharmaceutical leaders will be able to use the research results to see how their disease awareness programs stack up against industry averages and trends.
Sixteen leaders at 16 leading pharmaceutical and biotech organizations participated in this study. In addition, one global communications firm representing a biopharma client also participated. Four executives also took part in deep-dive operational interviews.
To learn more about this report, download a complimentary report excerpt at http://www.best-in-class.com/rr1447.htm.
For related research, visit our Best Practices, LLC website at www.best-in-class.com/.
ABOUT BEST PRACTICES, LLC
Best Practices, LLC is a leading benchmarking and advisory services firm serving pharmaceutical and medical device companies worldwide. Best Practices, LLC's clients include all the top 10 and most of the top 50 pharmaceutical companies. Best Practices, LLC believes in the profound principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/current-trends-in-how-the-pharmaceutical-industry-conducts-disease-state-awareness-campaigns-is-focus-of-research-study-300456968.html
SOURCE Best Practices, LLC
Subscribe to our Free Newsletters!
A patient's struggle with Issacs' syndrome with no cure. Also known as neuromyotonia it is a rare ...
Inguinal hernia surgery is a procedure to repair a weak spot or defect in the lower wall of the ...
Hypopituitarism is a rare disorder resulting from decreased secretion of one or more of the ...View All